Financials

  • Market Capitalization 1.69 B
  • Employee 133
  • Founded 2018
  • CEO N/A
  • Website www.maplightrx.com
  • Headquarter Delaware, United States
  • FIGI BBG01JZ5DBQ0
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2126
GHRS
GH Research PLC - Ordinary Shares
26.94 USD+0.64%+0.34%+32.97%+90.25%1.67 B USD
2130
FTRE
Fortrea Holdings Inc. - Common Stock
17.92 USD-0.61%+5.29%+7.50%+275.68%1.70 B USD
2135
ANAB
AnaptysBio, Inc. - Common Stock
55.83 USD-10.69%-14.57%-6.95%+58.61%1.62 B USD
2145
INVA
Innoviva, Inc. - Common Stock
21.89 USD+0.69%-2.41%-4.70%+22.84%1.62 B USD

Frequently asked questions about MapLight Therapeutics, Inc. - Common Stock

What is the MapLight Therapeutics, Inc. - Common Stock stock price today?

The current price of MapLight Therapeutics, Inc. - Common Stock (MPLT) is 37.3. Over the past 24 hours, the stock has changed by -1.61%. Follow the MPLT chart for real-time price dynamics.

What is the stock ticker of MapLight Therapeutics, Inc. - Common Stock?

MapLight Therapeutics, Inc. - Common Stock trades under the ticker MPLT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is MapLight Therapeutics, Inc. - Common Stock stock going up?

MPLT has changed by -3.19% over the last week, +33.36% over the last month, and +96.32% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was MapLight Therapeutics, Inc. - Common Stock net income for the last quarter?

MapLight Therapeutics, Inc. - Common Stock reported net income of -60.67 M for the last quarter. The previous quarter showed -79.55 M, which means net income changed by +23.73%.

How many employees does MapLight Therapeutics, Inc. - Common Stock have?

As of the latest available data, MapLight Therapeutics, Inc. - Common Stock has 133 employees. Workforce size can provide additional context about the company's scale and operations.

What is MapLight Therapeutics, Inc. - Common Stock EBITDA?

MapLight Therapeutics, Inc. - Common Stock EBITDA is -65.16 M, and its EBITDA margin is 1.63 M%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy MapLight Therapeutics, Inc. - Common Stock stock?

You can buy MapLight Therapeutics, Inc. - Common Stock (MPLT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in MapLight Therapeutics, Inc. - Common Stock stock?

Investing in MapLight Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MPLT chart and related analysis on metatrader.com as part of your research.